Gout
Conference Coverage
Urate-lowering therapy poses no harm to kidney function
WASHINGTON – Evidence supporting the renal benefits of urate-lowering therapy in patients with hyperuricemia and gout comes from two separate...
Conference Coverage
VIDEO: Allopurinol may not raise kidney disease risk in gout
WASHINGTON – Urate-lowering therapy (ULT) with allopurinol does not appear to increase the risk of chronic kidney disease in patients with gout...
From the Journals
ACP on gout: Treat to symptoms, not to urate targets
New gout treatment guidelines support the use of urate-lowering therapy but find no place for treating patients to achieve any specific serum...
From the Journals
Study provides best support to date for using ultrasound to detect gout
Ultrasound examination of patients with at least one swollen joint or a subcutaneous nodule detected gout with a sensitivity of 76.9% and...
From the Journals
Severe joint pain in adults with arthritis continues to rise
The prevalence of severe joint pain among adults with diagnosed arthritis continues to increase, researchers from the CDC reported in the Oct. 7...
News
Experts attempt first treat-to-target recommendations in gout
First treat-to-target recommendations for gout emphasize keeping serum uric acid levels below 6 mg/dL (less than 360 mmol/L).
News
A new model for gout: pharmacy-based care
News
New EULAR gout guidelines garner praise, criticism
Conference Coverage
Primary care gout patients often discontinue allopurinol
Key clinical point: A majority of newly diagnosed gout patients in the U.K.